OCGR array: An oral cancer genomic regional array for comparative genomic hybridization analysis

Oral Oncology

Volumn 40, Issue 5, 2004, Pages 511-519

  Garnis, Cathie ^a,b   Campbell, Jennifer ^a   Zhang, Lewei ^b   Rosin, Miriam P ^a   Lam, Wan L ^a,b  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Array CGH; Cancer; Copy number; Head and neck; High resolution; Microamplification; Oral; Profiling; Progression

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; FEMALE; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR CLONING; MOUTH CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DISEASE PROGRESSION; DNA PROBES; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-1; GENES, ERBB-1; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 1542360069     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2003.10.006     Document Type: Article

References (43)

1. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
2. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S.et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56:1996;2488-2492.
3. Lippman S.M., Hong W.K. Molecular markers of the risk of oral cancer. New England J. Med. 344:2001;1323-1326.
4. Gollin S.M. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck. 23:2001;238-253.
5. Partridge M., Emilion G., Falworth M., A'Hern R., Phillips E., Pateromichelakis S.et al. Patient-specific mutation databases for oral cancer. Int. J. Cancer. 84:1999;284-292.
6. Rosin M.P., Cheng X., Poh C., Lam W.L., Huang Y., Lovas J.et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia [comment]. Clin. Cancer Res. 6:2000;357-362.
7. Kresty L.A., Mallery S.R., Knobloch T.J., Song H., Lloyd M., Casto B.C. et al. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res. 62:2002;5295-5300.
8. Mao L., Lee J.S., Fan Y.H., Ro J.Y., Batsakis J.G., Lippman S.et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nature Med. 2:1996;682-685.
9. Lee J.I., Soria J.C., Hassan K., Liu D., Tang X., El-Naggar A.et al. Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Cancer Res. 61:2001;837-841.
10. Tanimoto K., Hayashi S., Tsuchiya E., Tokuchi Y., Kobayashi Y., Yoshiga K.et al. Abnormalities of the FHIT gene in human oral carcinogenesis. Br. J. Cancer. 82:2000;838-843.
11. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol. 36:2000;311-327.
12. Huang Q., Yu G.P., McCormick S.A., Mo J., Datta B., Mahimkar M.et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer. 34:2002;224-233.
13. Squire J.A., Bayani J., Luk C., Unwin L., Tokunaga J., MacMillan C.et al. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: by comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck. 24:2002;874-887.
14. Tremmel S.C., Gotte K., Popp S., Weber S., Hormann K., Bartram C.R.et al. Intratumoral genomic heterogeneity in advanced head and neck cancer detected by comparative genomic hybridization. Cancer Genet. Cytogenet. 144:2003;165-174.
15. Brieger J., Jacob R., Riazimand H.S., Essig E., Heinrich U.R., Bittinger F.et al. Chromosomal aberrations in premalignant and malignant squamous epithelium. Cancer Genet. Cytogenet. 144:2003;148-155.
16. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D.et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet. 20:1998;207-211.
17. Snijders A.M., Nowak N., Segraves R., Blackwood S., Brown N., Conroy J. et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nature Genet. 29:2001;263-264.
18. Bruder C.E., Hirvela C., Tapia-Paez I., Fransson I., Segraves R., Hamilton G.et al. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Human Mol. Genet. 10:2001;271-282.
19. Albertson D.G., Ylstra B., Segraves R., Collins C., Dairkee S.H., Kowbel D.et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genet. 25:2000;144-146.
20. Garnis C., Coe B.P., Ishkanian A., Zhang L., Rosin M.P., Lam W.L. Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer. Genes Chromosomes Cancer. 39(1):2004;93-98.
21. Zhang L., Michelsen C., Cheng X., Zeng T., Priddy R., Rosin M.P. Molecular analysis of oral lichen planus. A premalignant lesion? Am. J. Pathol. 151:1997;323-327.
22. McPherson J.D., Marra M., Hillier L., Waterston R.H., Chinwalla A., Wallis J.et al. A physical map of the human genome. Nature. 409:2001;934-941.
23. Veltman J.A., Fridlyand J., Pejavar S., Olshen A.B., Korkola J.E., DeVries S.et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 63:2003;2872-2880.
24. Arai K., Shibahara T., Yamamoto N., Noma H. The presence of candidate tumor suppressor gene loci at chromosome 3p for oral squamous cell carcinomas. Oral Oncol. 38:2002;763-771.
25. Kayahara H., Yamagata H., Tanioka H., Miki T., Hamakawa H. Frequent loss of heterozygosity at 3p25-p26 is associated with invasive oral squamous cell carcinoma. J. Human Genet. 46:2001;335-341.
26. Rowley H., Jones A., Spandidos D., Field J. Definition of a tumor suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers. Arch. Otolaryngol. - Head Neck Surg. 122:1996;497-501.
27. Sard L., Accornero P., Tornielli S., Delia D., Bunone G., Campiglio M.et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc. Nat. Acad. Sci. USA. 96:1999;8489-8492.
28. Kannan K., Munirajan A.K., Bhuvarahamurthy V., Mohanprasad B.K., Shankar P., Tsuchida N.et al. FHIT gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas. Oral Oncol. 36:2000;189-193.
29. Tseng J.E., Kemp B.L., Khuri F.R., Kurie J.M., Lee J.S., Zhou X.et al. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. Cancer Res. 59:1999;4798-4803.
30. Tanaka H., Shimada Y., Harada H., Shinoda M., Hatooka S., Imamura M.et al. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res. 58:1998;3429-3434.
31. Vermeulen K., Van Bockstaele D.R., Berneman Z.N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Proliferat. 36:2003;131-149.
32. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366:1993;704-707.
33. Ah-See K.W., Cooke T.G., Pickford I.R., Soutar D., Balmain A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res. 54:1994;1617-1621.
34. Nawroz H., van der Riet P., Hruban R.H., Koch W., Ruppert J.M., Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res. 54:1994;1152-1155.
35. van der Riet P., Nawroz H., Hruban R.H., Corio R., Tokino K., Koch W.et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 54:1994;1156-1158.
36. Xia W., Lau Y.K., Zhang H.Z., Xiao F.Y., Johnston D.A., Liu A.R.et al. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin. Cancer Res. 5:1999;4164-4174.
37. Bei R., Pompa G., Vitolo D., Moriconi E., Ciocci L., Quaranta M.et al. Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell arcinoma. J. Pathol. 195:2001;343-348.
38. Kuo M.Y., Lin C.Y., Hahn L.J., Cheng S.J., Chiang C.P. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. J. Oral Pathol. Med. 28:1999;165-169.
39. Shintani S., Mihara M., Nakahara Y., Kiyota A., Ueyama Y., Matsumura T. et al. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol. 38:2002;235-243.
40. Huang X., Gollin S.M., Raja S., Godfrey T.E. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc. Nat. Acad. Sci. USA. 99:2002;11369-11374.
41. Muller D., Millon R., Velten M., Bronner G., Jung G., Engelmann A.et al. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome. Eur. J. Cancer. 33:1997;2203-2210.
42. Bekri S., Adelaide J., Merscher S., Grosgeorge J., Caroli-Bosc F., Perucca-Lostanlen D.et al. Detailed map of a region commonly amplified at 11q13. → q14 in human breast carcinoma Cytogenet. Cell Genet. 79:1997;125-131.
43. Corvi R., Berger N., Balczon R., Romeo G. RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma. Oncogene. 19:2000;4236-4242.